- Report
- May 2024
- 129 Pages
Global
From €5791EUR$6,499USD£5,024GBP
- Report
- May 2024
- 138 Pages
Global
From €5791EUR$6,499USD£5,024GBP
- Report
- May 2024
- 182 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- April 2024
- 183 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- November 2023
- 78 Pages
France
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- November 2023
- 78 Pages
Germany
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- November 2023
- 83 Pages
Germany
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- October 2023
- 73 Pages
Canada
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- March 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- March 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- January 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- January 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- February 2024
- 131 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- June 2024
- 200 Pages
Global
From €7084EUR$7,950USD£6,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7084EUR$7,950USD£6,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7084EUR$7,950USD£6,146GBP
- Report
- April 2024
- 143 Pages
Global
From €7084EUR$7,950USD£6,146GBP
- Report
- March 2024
- 174 Pages
Global
From €6683EUR$7,500USD£5,798GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more